Cenegenics Medical Inst Boston is categorized under Health Services in Boston, MA and active since 2011.
Cenegenics Medical Inst Boston was established in 2011, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Kate Sanders at the company’s single location by writing to 15 Broad St, Boston, Massachusetts MA 02109 or by phoning (857) 263-7493. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cenegenics Medical Inst Boston |
Contact Person: | Kate Sanders |
Address: | 15 Broad St, Boston, Massachusetts 02109 |
Phone Number: | (857) 263-7493 |
Website Address: | cenegenicsphysicians.com |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
SIC Code: | 8099 |
NAICS Code: | 6214930 |
Share This Business: |
Cenegenics Medical Inst Boston was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Kate Sanders for inquiries that concern Cenegenics Medical Inst Boston by calling the company number (857) 263-7493, as your correspondence is most welcome. Additionally, the physical location of the single location of Cenegenics Medical Inst Boston can be found at the coordinates 42.358667,-71.054383 as well as the street address 15 Broad St in Boston, Massachusetts 02109.
For its online presence, you may visit Cenegenics Medical Inst Boston’s website at cenegenicsphysicians.com and engage with its social media outlets through on Twitter and on Facebook.